US and EU enter Mutual Recognition Agreement for drug manufacturing inspections
The FDA and EMA have agreed to rely on each other’s assessment of pharmaceutical manufacturing sites to reduce duplicative work.
List view / Grid view
The FDA and EMA have agreed to rely on each other’s assessment of pharmaceutical manufacturing sites to reduce duplicative work.
PR001 has received Fast Track Designation from the regulatory body for the treatment of Parkinson’s disease.
New guidance drafts have been announced by the FDA to improve patients understanding and keep information consistent.
A study has shown the warning letters the FDA distributes have decreased by a third since Trump came to office.
An injection to treat NMOSD has been given approval by the FDA and has received orphan drug designation.
Walmart has joined a consortium that’s attempting to build a blockchain for tracking pharmaceutical supply chains.
The Food and Drug Administration has released a list of 40 drugs used to treat hypertension and heart failure that don’t contain any known carcinogens...
As Dr Scott Gottlieb steps down from his role next month, Dr Ned Sharpless has been announced as his short-term replacement...
The FDA has prioritised the review of this drug application after multiple recalls of generic valsartan products from several manufacturers...
Scott Gottlieb has announced that he will resign from the position of commissioner of the US Food and Drug Administration (FDA) at the end of the month...
FDA is 'deeply concerned' about a third type of nitrosamine impurity detected in angiotensin II receptor blocker (ARB) medicines...
The pilot project will test innovative and emerging approaches for enhanced tracing and verification of prescription drugs in the US...
Results did not confirm the clinical benefit of Lartruvo in combination with doxorubicin compared to doxorubicin alone…
A generic version of the seizure drug Sabril (vigabatrin) has been approved by the FDA...
A formulation of treprostinil as an inhaled dry powder has proven to be safe and effective, as reported in the safety analysis of a Phase III trial...